Skip to main content
. 2020 Nov 5;12(11):1258. doi: 10.3390/v12111258

Figure 3.

Figure 3

Immunoreactivity of peptGLZIKALIVax mutants with anti-ZIKALIVax immune serum. The O.D450 or signal intensity of individual anti-ZIKALIVax immune sera in relation to peptGLZIKALIVax and its mutants at positions 8 and 12 (A) or 14 (B) measured through peptide-based ELISA. Peptides at concentration of 3 µg mL−1 were incubated with individual anti-ZIKALIVax immune sera (n = 7) (ZIKALIVax serum) showing the higher reactivity with peptGLZIKALIVax at dilution 1:200 (Figure 2B). Serum of mice (n = 7) that received heat-inactivated ZIKALIVax at dilution 1:200 served as a control serum. Each closed circle represents an individual mouse.